UT Southwestern Medical Center and Parkland Hospital
Welcome,         Profile    Billing    Logout  
 5 Trials 
23 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Singal, Amit
TRACER, NCT06084234: National Liver Cancer Screening Trial

Recruiting
4
5500
US
GALAD, Liver Ultrasound with or without AFP
University of Texas Southwestern Medical Center, National Cancer Institute (NCI), University of Pennsylvania, University of Michigan, Dana-Farber Cancer Institute, Baylor College of Medicine, Fred Hutchinson Cancer Center
Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis, Hepatitis B
12/29
12/34
LOST-B, NCT05537402: LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCC

Recruiting
2
204
US
Atezolizumab and bevacizumab, transarterial chemoembolization (TACE) or transarterial radioembolization (TARE
University of Texas Southwestern Medical Center, Genentech, Inc.
Hepatocellular Carcinoma
01/28
01/30
NCT03756051: Harms of Hepatocellular Carcinoma Surveillance

Completed
N/A
2871
US
Prospective Longitudinal Data, Surveys and Semi-structured Interviews
University of Texas Southwestern Medical Center, National Cancer Institute (NCI), Parkland Health and Hospital System, Baylor College of Medicine, Michael E. DeBakey VA Medical Center, Kaiser Permanente
Carcinoma, Hepatocellular
06/22
06/22
NCT06184152: CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules

Recruiting
N/A
600
US
CEUS imaging, aMRI imaging
University of Texas Southwestern Medical Center, University of Michigan
HCC, Hepatocellular Carcinoma
11/28
11/28
NCT03878550: Case-Control Study of the Glycotest™ HCC Panel Vs AFP for the Detection of Early-stage Hepatocellular Carcinoma

Active, not recruiting
N/A
766
US, RoW
Glycotest, Inc.
Carcinoma, Hepatocellular, Cirrhosis, Liver
08/23
12/25
ALTUS, NCT05064553: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Recruiting
N/A
2500
US
Study CT/MRI Imaging, Standard of Care CT/MRI Imaging, Oncoguard™ Liver Test
Exact Sciences Corporation
Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatitis B, Cirrhosis, Liver Cancer
01/25
04/26
Parikh, Neehar
TRACER, NCT06084234: National Liver Cancer Screening Trial

Recruiting
4
5500
US
GALAD, Liver Ultrasound with or without AFP
University of Texas Southwestern Medical Center, National Cancer Institute (NCI), University of Pennsylvania, University of Michigan, Dana-Farber Cancer Institute, Baylor College of Medicine, Fred Hutchinson Cancer Center
Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis, Hepatitis B
12/29
12/34
NCT03878550: Case-Control Study of the Glycotest™ HCC Panel Vs AFP for the Detection of Early-stage Hepatocellular Carcinoma

Active, not recruiting
N/A
766
US, RoW
Glycotest, Inc.
Carcinoma, Hepatocellular, Cirrhosis, Liver
08/23
12/25
ALTUS, NCT05064553: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Recruiting
N/A
2500
US
Study CT/MRI Imaging, Standard of Care CT/MRI Imaging, Oncoguard™ Liver Test
Exact Sciences Corporation
Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatitis B, Cirrhosis, Liver Cancer
01/25
04/26
TARGET-HCC, NCT02954094: A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Recruiting
N/A
10000
Europe, US
Target PharmaSolutions, Inc.
Hepatocellular Cancer
10/25
10/25
Deodhar, Sneha
TRACER, NCT06084234: National Liver Cancer Screening Trial

Recruiting
4
5500
US
GALAD, Liver Ultrasound with or without AFP
University of Texas Southwestern Medical Center, National Cancer Institute (NCI), University of Pennsylvania, University of Michigan, Dana-Farber Cancer Institute, Baylor College of Medicine, Fred Hutchinson Cancer Center
Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis, Hepatitis B
12/29
12/34
NCT06184152: CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules

Recruiting
N/A
600
US
CEUS imaging, aMRI imaging
University of Texas Southwestern Medical Center, University of Michigan
HCC, Hepatocellular Carcinoma
11/28
11/28
TARGET-HCC, NCT02954094: A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Recruiting
N/A
10000
Europe, US
Target PharmaSolutions, Inc.
Hepatocellular Cancer
10/25
10/25
DONATE-FH, NCT05693701: Multicomponent Intervention Study- Blood Donors With High Cholesterol

Recruiting
N/A
100
US
Implementation Strategy Bundle, Usual care notification
University of Texas Southwestern Medical Center, National Heart, Lung, and Blood Institute (NHLBI)
Lipid Metabolism Disorder
02/27
02/27
NCT05367297: South Asians and Coronary Plaque Registry

Recruiting
N/A
300
US
Coronary CT Angiogram
University of Texas Southwestern Medical Center
Coronary Artery Disease, Heart Diseases
04/27
04/27
NCT04156997: Extreme Lipids Repository

Active, not recruiting
N/A
250
US
No intervention is involved in this study
University of Texas Southwestern Medical Center, National Heart, Lung, and Blood Institute (NHLBI)
Lipoprotein Disorder
05/29
05/29
Peruski, Jessica
TRACER, NCT06084234: National Liver Cancer Screening Trial

Recruiting
4
5500
US
GALAD, Liver Ultrasound with or without AFP
University of Texas Southwestern Medical Center, National Cancer Institute (NCI), University of Pennsylvania, University of Michigan, Dana-Farber Cancer Institute, Baylor College of Medicine, Fred Hutchinson Cancer Center
Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis, Hepatitis B
12/29
12/34
SRF388-201, NCT05359861: Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma

Active, not recruiting
2
134
US, RoW
SRF388, Atezolizumab, Tecentriq, Bevacizumab, Avastin, Placebo
Coherus Biosciences, Inc.
Hepatocellular Carcinoma
06/25
06/25
ALTUS, NCT05064553: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Recruiting
N/A
2500
US
Study CT/MRI Imaging, Standard of Care CT/MRI Imaging, Oncoguard™ Liver Test
Exact Sciences Corporation
Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatitis B, Cirrhosis, Liver Cancer
01/25
04/26
TARGET-HCC, NCT02954094: A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Recruiting
N/A
10000
Europe, US
Target PharmaSolutions, Inc.
Hepatocellular Cancer
10/25
10/25
MAPLE, NCT04793360: Molecular Assessment and Profiling of Liver Transplant Recipients

Active, not recruiting
N/A
1500
US
LiverCare
CareDx
Liver Transplantation, Biomarkers
12/27
03/28
Robinson, Shay
TRACER, NCT06084234: National Liver Cancer Screening Trial

Recruiting
4
5500
US
GALAD, Liver Ultrasound with or without AFP
University of Texas Southwestern Medical Center, National Cancer Institute (NCI), University of Pennsylvania, University of Michigan, Dana-Farber Cancer Institute, Baylor College of Medicine, Fred Hutchinson Cancer Center
Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis, Hepatitis B
12/29
12/34
Robison, Shay
TRACER, NCT06084234: National Liver Cancer Screening Trial

Recruiting
4
5500
US
GALAD, Liver Ultrasound with or without AFP
University of Texas Southwestern Medical Center, National Cancer Institute (NCI), University of Pennsylvania, University of Michigan, Dana-Farber Cancer Institute, Baylor College of Medicine, Fred Hutchinson Cancer Center
Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis, Hepatitis B
12/29
12/34
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Singal, Amit
TRACER, NCT06084234: National Liver Cancer Screening Trial

Recruiting
4
5500
US
GALAD, Liver Ultrasound with or without AFP
University of Texas Southwestern Medical Center, National Cancer Institute (NCI), University of Pennsylvania, University of Michigan, Dana-Farber Cancer Institute, Baylor College of Medicine, Fred Hutchinson Cancer Center
Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis, Hepatitis B
12/29
12/34
LOST-B, NCT05537402: LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCC

Recruiting
2
204
US
Atezolizumab and bevacizumab, transarterial chemoembolization (TACE) or transarterial radioembolization (TARE
University of Texas Southwestern Medical Center, Genentech, Inc.
Hepatocellular Carcinoma
01/28
01/30
NCT03756051: Harms of Hepatocellular Carcinoma Surveillance

Completed
N/A
2871
US
Prospective Longitudinal Data, Surveys and Semi-structured Interviews
University of Texas Southwestern Medical Center, National Cancer Institute (NCI), Parkland Health and Hospital System, Baylor College of Medicine, Michael E. DeBakey VA Medical Center, Kaiser Permanente
Carcinoma, Hepatocellular
06/22
06/22
NCT06184152: CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules

Recruiting
N/A
600
US
CEUS imaging, aMRI imaging
University of Texas Southwestern Medical Center, University of Michigan
HCC, Hepatocellular Carcinoma
11/28
11/28
NCT03878550: Case-Control Study of the Glycotest™ HCC Panel Vs AFP for the Detection of Early-stage Hepatocellular Carcinoma

Active, not recruiting
N/A
766
US, RoW
Glycotest, Inc.
Carcinoma, Hepatocellular, Cirrhosis, Liver
08/23
12/25
ALTUS, NCT05064553: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Recruiting
N/A
2500
US
Study CT/MRI Imaging, Standard of Care CT/MRI Imaging, Oncoguard™ Liver Test
Exact Sciences Corporation
Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatitis B, Cirrhosis, Liver Cancer
01/25
04/26
Parikh, Neehar
TRACER, NCT06084234: National Liver Cancer Screening Trial

Recruiting
4
5500
US
GALAD, Liver Ultrasound with or without AFP
University of Texas Southwestern Medical Center, National Cancer Institute (NCI), University of Pennsylvania, University of Michigan, Dana-Farber Cancer Institute, Baylor College of Medicine, Fred Hutchinson Cancer Center
Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis, Hepatitis B
12/29
12/34
NCT03878550: Case-Control Study of the Glycotest™ HCC Panel Vs AFP for the Detection of Early-stage Hepatocellular Carcinoma

Active, not recruiting
N/A
766
US, RoW
Glycotest, Inc.
Carcinoma, Hepatocellular, Cirrhosis, Liver
08/23
12/25
ALTUS, NCT05064553: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Recruiting
N/A
2500
US
Study CT/MRI Imaging, Standard of Care CT/MRI Imaging, Oncoguard™ Liver Test
Exact Sciences Corporation
Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatitis B, Cirrhosis, Liver Cancer
01/25
04/26
TARGET-HCC, NCT02954094: A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Recruiting
N/A
10000
Europe, US
Target PharmaSolutions, Inc.
Hepatocellular Cancer
10/25
10/25
Deodhar, Sneha
TRACER, NCT06084234: National Liver Cancer Screening Trial

Recruiting
4
5500
US
GALAD, Liver Ultrasound with or without AFP
University of Texas Southwestern Medical Center, National Cancer Institute (NCI), University of Pennsylvania, University of Michigan, Dana-Farber Cancer Institute, Baylor College of Medicine, Fred Hutchinson Cancer Center
Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis, Hepatitis B
12/29
12/34
NCT06184152: CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules

Recruiting
N/A
600
US
CEUS imaging, aMRI imaging
University of Texas Southwestern Medical Center, University of Michigan
HCC, Hepatocellular Carcinoma
11/28
11/28
TARGET-HCC, NCT02954094: A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Recruiting
N/A
10000
Europe, US
Target PharmaSolutions, Inc.
Hepatocellular Cancer
10/25
10/25
DONATE-FH, NCT05693701: Multicomponent Intervention Study- Blood Donors With High Cholesterol

Recruiting
N/A
100
US
Implementation Strategy Bundle, Usual care notification
University of Texas Southwestern Medical Center, National Heart, Lung, and Blood Institute (NHLBI)
Lipid Metabolism Disorder
02/27
02/27
NCT05367297: South Asians and Coronary Plaque Registry

Recruiting
N/A
300
US
Coronary CT Angiogram
University of Texas Southwestern Medical Center
Coronary Artery Disease, Heart Diseases
04/27
04/27
NCT04156997: Extreme Lipids Repository

Active, not recruiting
N/A
250
US
No intervention is involved in this study
University of Texas Southwestern Medical Center, National Heart, Lung, and Blood Institute (NHLBI)
Lipoprotein Disorder
05/29
05/29
Peruski, Jessica
TRACER, NCT06084234: National Liver Cancer Screening Trial

Recruiting
4
5500
US
GALAD, Liver Ultrasound with or without AFP
University of Texas Southwestern Medical Center, National Cancer Institute (NCI), University of Pennsylvania, University of Michigan, Dana-Farber Cancer Institute, Baylor College of Medicine, Fred Hutchinson Cancer Center
Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis, Hepatitis B
12/29
12/34
SRF388-201, NCT05359861: Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma

Active, not recruiting
2
134
US, RoW
SRF388, Atezolizumab, Tecentriq, Bevacizumab, Avastin, Placebo
Coherus Biosciences, Inc.
Hepatocellular Carcinoma
06/25
06/25
ALTUS, NCT05064553: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Recruiting
N/A
2500
US
Study CT/MRI Imaging, Standard of Care CT/MRI Imaging, Oncoguard™ Liver Test
Exact Sciences Corporation
Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatitis B, Cirrhosis, Liver Cancer
01/25
04/26
TARGET-HCC, NCT02954094: A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Recruiting
N/A
10000
Europe, US
Target PharmaSolutions, Inc.
Hepatocellular Cancer
10/25
10/25
MAPLE, NCT04793360: Molecular Assessment and Profiling of Liver Transplant Recipients

Active, not recruiting
N/A
1500
US
LiverCare
CareDx
Liver Transplantation, Biomarkers
12/27
03/28
Robinson, Shay
TRACER, NCT06084234: National Liver Cancer Screening Trial

Recruiting
4
5500
US
GALAD, Liver Ultrasound with or without AFP
University of Texas Southwestern Medical Center, National Cancer Institute (NCI), University of Pennsylvania, University of Michigan, Dana-Farber Cancer Institute, Baylor College of Medicine, Fred Hutchinson Cancer Center
Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis, Hepatitis B
12/29
12/34
Robison, Shay
TRACER, NCT06084234: National Liver Cancer Screening Trial

Recruiting
4
5500
US
GALAD, Liver Ultrasound with or without AFP
University of Texas Southwestern Medical Center, National Cancer Institute (NCI), University of Pennsylvania, University of Michigan, Dana-Farber Cancer Institute, Baylor College of Medicine, Fred Hutchinson Cancer Center
Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis, Hepatitis B
12/29
12/34

Download Options